Skip to content

Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy

Arthrodesis Gleno Humeral Under Arthroscopy in the Sequelae of Plexus Brachial Evaluation of the Technical Feasibility

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02566382
Acronym
DESEP
Enrollment
1
Registered
2015-10-02
Start date
2015-09-30
Completion date
2017-10-31
Last updated
2017-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopy Arthrodesis Gleno-humeral

Brief summary

Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.

Detailed description

This trial is about the arthrodesis shoulder blade/humerus under arthroscopy. The main aim of this study is to be able to carry out a fusion scapula-humeral supplements in 6 months. It is required to provide the benefice risk over to reduce the hospitalisation 48 hours.

Interventions

PROCEDUREarthroscopy arthrodesis of the shoulder

The shoulder surgery will be realized under arthroscopy only

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient having a deficit scapula-humeral mobility * Impossibility of being operated for a preserving nervous surgery * Patient affiliation with a social security * Patient who signed inform consent

Exclusion criteria

* Patient with No mobility in all the articulations of the shoulder * Callus malunion of the higher end of the humerus or the glen of the scapula * Unable to sign an inform consent

Design outcomes

Primary

MeasureTime frameDescription
Radiological fusion gleno humeral on side and front view after the 6th month of the arthroscopy interventional6 monthsThis outcome will be considered like a success if the investigators get a continuous bone matrix between the humeral head and glenoid on the scapula and bone frame continues between the humeral head and the acromion. This evaluation will be done by radiographies.

Secondary

MeasureTime frameDescription
Blood loss3 daysThe blood loss during and after the surgery will be calculated and will be considered like a success if the total blood loss are less than 600ml.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026